These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 19638649

  • 1. Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study.
    Castle PE, Rodríguez AC, Burk RD, Herrero R, Wacholder S, Alfaro M, Morales J, Guillen D, Sherman ME, Solomon D, Schiffman M, Proyecto Epidemiológico Guanacaste (PEG) Group.
    BMJ; 2009 Jul 28; 339():b2569. PubMed ID: 19638649
    [Abstract] [Full Text] [Related]

  • 2. Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,
    Bratti MC, Rodríguez AC, Schiffman M, Hildesheim A, Morales J, Alfaro M, Guillén D, Hutchinson M, Sherman ME, Eklund C, Schussler J, Buckland J, Morera LA, Cárdenas F, Barrantes M, Pérez E, Cox TJ, Burk RD, Herrero R.
    Rev Panam Salud Publica; 2004 Feb 28; 15(2):75-89. PubMed ID: 15030652
    [Abstract] [Full Text] [Related]

  • 3. Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3.
    Kreimer AR, Katki HA, Schiffman M, Wheeler CM, Castle PE, ASCUS-LSIL Triage Study Group.
    Cancer Epidemiol Biomarkers Prev; 2007 Jan 28; 16(1):11-6. PubMed ID: 17220326
    [Abstract] [Full Text] [Related]

  • 4. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.
    Rodríguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillén D, Alfaro M, Morales J, Hutchinson M, Katki H, Cheung L, Wacholder S, Burk RD.
    J Natl Cancer Inst; 2010 Mar 03; 102(5):315-24. PubMed ID: 20157096
    [Abstract] [Full Text] [Related]

  • 5. Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease.
    Kreimer AR, Guido RS, Solomon D, Schiffman M, Wacholder S, Jeronimo J, Wheeler CM, Castle PE.
    Cancer Epidemiol Biomarkers Prev; 2006 May 03; 15(5):908-14. PubMed ID: 16702369
    [Abstract] [Full Text] [Related]

  • 6. Long-term cervical precancer outcomes after a negative DNA- or RNA-based human papillomavirus test result.
    Strang THR, Gottschlich A, Cook DA, Smith LW, Gondara L, Franco EL, van Niekerk DJ, Ogilvie GS, Krajden M.
    Am J Obstet Gynecol; 2021 Nov 03; 225(5):511.e1-511.e7. PubMed ID: 34081897
    [Abstract] [Full Text] [Related]

  • 7. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J.
    Health Technol Assess; 2014 Apr 03; 18(23):1-196. PubMed ID: 24762804
    [Abstract] [Full Text] [Related]

  • 8. Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3.
    Rodríguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillén D, Alfaro M, Morales J, Hutchinson M, Cheung L, Wacholder S, Burk RD.
    Int J Cancer; 2012 Oct 15; 131(8):1874-81. PubMed ID: 22213126
    [Abstract] [Full Text] [Related]

  • 9. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.
    Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M.
    J Natl Cancer Inst; 2005 Jul 20; 97(14):1072-9. PubMed ID: 16030305
    [Abstract] [Full Text] [Related]

  • 10. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study.
    Castle PE, Gravitt PE, Solomon D, Wheeler CM, Schiffman M.
    J Clin Microbiol; 2008 Jan 20; 46(1):109-17. PubMed ID: 17989194
    [Abstract] [Full Text] [Related]

  • 11. Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection.
    Keller MJ, Burk RD, Xie X, Anastos K, Massad LS, Minkoff H, Xue X, D'Souza G, Watts DH, Levine AM, Castle PE, Colie C, Palefsky JM, Strickler HD.
    JAMA; 2012 Jul 25; 308(4):362-9. PubMed ID: 22820789
    [Abstract] [Full Text] [Related]

  • 12. Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.
    Safaeian M, Solomon D, Wacholder S, Schiffman M, Castle P.
    Obstet Gynecol; 2007 Jun 25; 109(6):1325-31. PubMed ID: 17540804
    [Abstract] [Full Text] [Related]

  • 13. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
    Song F, Yan P, Huang X, Wang C, Du H, Qu X, Wu R.
    BMC Cancer; 2022 Jan 06; 22(1):42. PubMed ID: 34991494
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
    Ouh YT, Min KJ, Cho HW, Ki M, Oh JK, Shin SY, Hong JH, Lee JK.
    J Gynecol Oncol; 2018 Jan 06; 29(1):e14. PubMed ID: 29185272
    [Abstract] [Full Text] [Related]

  • 15. Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project.
    Herrero R, Schiffman MH, Bratti C, Hildesheim A, Balmaceda I, Sherman ME, Greenberg M, Cárdenas F, Gómez V, Helgesen K, Morales J, Hutchinson M, Mango L, Alfaro M, Potischman NW, Wacholder S, Swanson C, Brinton LA.
    Rev Panam Salud Publica; 1997 May 06; 1(5):362-75. PubMed ID: 9180057
    [Abstract] [Full Text] [Related]

  • 16. Human papillomavirus genotypes and risk of persistence and progression in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2.
    Damgaard RK, Jenkins D, Stoler MH, de Koning M, van de Sandt M, Lycke KD, Kahlert J, Gravitt PE, Quint WGV, Steiniche T, Petersen LK, Hammer A.
    Am J Obstet Gynecol; 2024 Jun 06; 230(6):655.e1-655.e10. PubMed ID: 38336125
    [Abstract] [Full Text] [Related]

  • 17. Evidence of Decreased Long-term Risk of Cervical Precancer after Negative Primary HPV Screens Compared with Negative Cytology Screens in a Longitudinal Cohort Study.
    Gottschlich A, Hong Q, Gondara L, Alam MS, Cook DA, Martin RE, Lee M, Melnikow J, Peacock S, Proctor L, Stuart G, Franco EL, Krajden M, Smith LW, Ogilvie GS.
    Cancer Epidemiol Biomarkers Prev; 2024 Jul 01; 33(7):904-911. PubMed ID: 38773687
    [Abstract] [Full Text] [Related]

  • 18. A Pooled Analysis to Compare the Clinical Characteristics of Human Papillomavirus-positive and -Negative Cervical Precancers.
    Castle PE, Pierz AJ, Adcock R, Aslam S, Basu PS, Belinson JL, Cuzick J, El-Zein M, Ferreccio C, Firnhaber C, Franco EL, Gravitt PE, Isidean SD, Lin J, Mahmud SM, Monsonego J, Muwonge R, Ratnam S, Safaeian M, Schiffman M, Smith JS, Swarts A, Wright TC, Van De Wyngard V, Xi LF.
    Cancer Prev Res (Phila); 2020 Oct 01; 13(10):829-840. PubMed ID: 32655005
    [Abstract] [Full Text] [Related]

  • 19. High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease.
    Gravitt PE, Kovacic MB, Herrero R, Schiffman M, Bratti C, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Rodriguez AC, Burk RD.
    Int J Cancer; 2007 Dec 15; 121(12):2787-93. PubMed ID: 17722112
    [Abstract] [Full Text] [Related]

  • 20. Prospective comparison of hybrid capture 2 and SPF₁₀-LiPA for carcinogenic human papillomavirus detection and risk prediction of cervical cancer: a population-based cohort study in China.
    Dong L, Feng RM, Zhang L, Xu XQ, Zhao XL, Wang MZ, Qiao YL, Zhao FH.
    J Gynecol Oncol; 2017 Sep 15; 28(5):e66. PubMed ID: 28657227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.